← Medical directoryActive ingredient
Febuxostat
A urate-lowering drug. Following the CARES trial, which showed higher all-cause and cardiovascular mortality compared with allopurinol, the AEMPS advises against its use in people who have had a heart attack, stroke or unstable angina unless there is no alternative.
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.





